MedTrace Logo

Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder

NCT00226135 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2007-04-05

No results posted yet for this study

Summary

The purpose of this study is to compare lamotrigine with lithium in the long term treatment of bipolar disorder in terms of new episode preventive potentials.

Conditions

Interventions

DRUG

lithium or lamotrigine

Sponsors & Collaborators

  • Stanley Medical Research Institute

    collaborator OTHER

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Rasmus W Licht, MD, PhD · Aarhus University Psychiatric Hospital, Risskov, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Completion
2006-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00226135 on ClinicalTrials.gov